weedhoppa

[SuperAlerts] CFRX ContraFect Initiated With an Outperform Rating and $7 Price Target by William Blair's Biotech team (strong note)

beach_trades

[SuperAlerts] CFRX later today Presentation Title: Staphylococcus aureus Resistance to Lysin CF-301 Does Not Arise in Human Serum Session Day & Time: Monday, June 20, 2016 3:45 PM - 4:00 PM ET

Page
of 21